Literature DB >> 16696051

Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selection.

R G Owen1, A P Haynes, P A Evans, R J Johnson, A C Rawstron, G McQuaker, G M Smith, M C Galvin, D L Barnard, N H Russell, J A Child, G J Morgan.   

Abstract

Aims-To determine the extent of clonal cell contamination of peripheral blood progenitor cell (PBPC) collections in patients with multiple myeloma (MM) and to assess the purging efficacy of CD34 positive selection.Methods-PBPC collections from 29 patients with MM were analysed for the presence of clonal immunoglobulin heavy chain (IgH) gene rearrangements with a fluorescence based PCR technique. In addition, the PBPC from eight of the 29 patients were "purged" by selection of CD34 positive haematopoietic progenitors with an avidin-biotin immunoabsorption column (Ceprate). In each case the unmanipulated PBPC, CD34 positive and waste fractions were all assessed for the presence of clonal IgH rearrangements.Results-Clonal IgH rearrangements (identical with those demonstrated in diagnostic bone marrow samples) were demonstrated in 10 (35%) of 29 cases and seemed to be confined to those with significant residual bone marrow disease. Clonal rearrangements were evident in the PBPC of two of the eight patients who underwent CD34 selection; in both instances a "clonal purge" was seen as it was not possible to demonstrate the clonal rearrangement in the CD34 positive fraction. In four of the six remaining cases the normal polyclonal fingerprint could not be demonstrated in the CD34 positive fraction, which is consistent with a significant reduction in contaminating B cells.Conclusions-Clonal cells contaminate PBPC collections in a significant proportion of patients with MM and may be eliminated by CD34 positive selection.

Entities:  

Year:  1996        PMID: 16696051      PMCID: PMC408031          DOI: 10.1136/mp.49.2.m112

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  17 in total

1.  Intensive treatment of multiple myeloma and criteria for complete remission.

Authors:  M E Gore; P J Selby; C Viner; P I Clark; M Meldrum; B Millar; J Bell; J A Maitland; S Milan; I R Judson
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

2.  Circulating monoclonal B lymphocytes in multiple myeloma.

Authors:  E K Chiu; K Ganeshaguru; A V Hoffbrand; A B Mehta
Journal:  Br J Haematol       Date:  1989-05       Impact factor: 6.998

3.  Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma.

Authors:  J Berenson; R Wong; K Kim; N Brown; A Lichtenstein
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

4.  Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies.

Authors:  I Van Riet; C Heirman; P Lacor; M De Waele; K Thielemans; B Van Camp
Journal:  Br J Haematol       Date:  1989-11       Impact factor: 6.998

5.  Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.

Authors:  Y Gazitt; C C Reading; R Hoffman; A Wickrema; D H Vesole; S Jagannath; J Condino; B Lee; B Barlogie; G Tricot
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

6.  Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.

Authors:  W Brugger; K J Bross; M Glatt; F Weber; R Mertelsmann; L Kanz
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

7.  Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

Authors:  D Billadeau; L Quam; W Thomas; N Kay; P Greipp; R Kyle; M M Oken; B Van Ness
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

8.  Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.

Authors:  J G Gribben; A S Freedman; D Neuberg; D C Roy; K W Blake; S D Woo; M L Grossbard; S N Rabinowe; F Coral; G J Freeman
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

9.  Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation.

Authors:  J E Hardingham; D Kotasek; R E Sage; A Dobrovic; T Gooley; B M Dale
Journal:  Bone Marrow Transplant       Date:  1993-01       Impact factor: 5.483

10.  The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma.

Authors:  R A Vescio; C H Hong; J Cao; A Kim; G J Schiller; A K Lichtenstein; R J Berenson; J R Berenson
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

View more
  1 in total

1.  Assessment of IgH PCR strategies in multiple myeloma.

Authors:  R G Owen; R J Johnson; A C Rawstron; P A Evans; A Jack; G M Smith; J A Child; G J Morgan
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.